BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14750537)

  • 21. Hormone replacement therapy and risk of colon and rectal cancer.
    Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.
    Zandi PP; Carlson MC; Plassman BL; Welsh-Bohmer KA; Mayer LS; Steffens DC; Breitner JC;
    JAMA; 2002 Nov; 288(17):2123-9. PubMed ID: 12413371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone therapy in relation to survival from large bowel cancer.
    Newcomb PA; Chia VM; Hampton JM; Doria-Rose VP; Trentham Dietz A
    Cancer Causes Control; 2009 May; 20(4):409-16. PubMed ID: 18998219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy is associated with improved survival in women with advanced heart failure.
    Lindenfeld J; Ghali JK; Krause-Steinrauf HJ; Khan S; Adams K; Goldman S; Peberdy MA; Yancy C; Thaneemit-Chen S; Larsen RL; Young J; Lowes B; Rosenberg YD;
    J Am Coll Cardiol; 2003 Oct; 42(7):1238-45. PubMed ID: 14522488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of menopausal hormones and risk of colorectal cancer (United States).
    Troisi R; Schairer C; Chow WH; Schatzkin A; Brinton LA; Fraumeni JF
    Cancer Causes Control; 1997 Mar; 8(2):130-8. PubMed ID: 9134236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case-control study of increased mammographic breast density response to hormone replacement therapy.
    Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
    Gapstur SM; Morrow M; Sellers TA
    JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis.
    Fletcher AS; Erbas B; Kavanagh AM; Hart S; Rodger A; Gertig DM
    Breast; 2005 Jun; 14(3):192-200. PubMed ID: 15927828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer and hormone replacement therapy: an unexpected finding.
    Franceschi S; La Vecchia C
    Eur J Cancer Prev; 1998 Dec; 7(6):427-38. PubMed ID: 9926290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women.
    Qureshi AI; Malik AA; Saeed O; Defillo A; Sherr GT; Suri MF
    J Neurosurg; 2016 Jan; 124(1):45-50. PubMed ID: 26162033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
    Mascarenhas C; Lambe M; Bellocco R; Bergfeldt K; Riman T; Persson I; Weiderpass E
    Int J Cancer; 2006 Dec; 119(12):2907-15. PubMed ID: 16998830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA).
    Jacobs EJ; White E; Weiss NS
    Cancer Causes Control; 1994 Jul; 5(4):359-66. PubMed ID: 8080948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
    Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
    Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone replacement therapy and associated risk of stroke in postmenopausal women.
    Lemaitre RN; Heckbert SR; Psaty BM; Smith NL; Kaplan RC; Longstreth WT
    Arch Intern Med; 2002 Sep; 162(17):1954-60. PubMed ID: 12230417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.
    Grodstein F; Newcomb PA; Stampfer MJ
    Am J Med; 1999 May; 106(5):574-82. PubMed ID: 10335731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen replacement therapy and colorectal cancer risk in elderly women.
    Paganini-Hill A
    Dis Colon Rectum; 1999 Oct; 42(10):1300-5. PubMed ID: 10528768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.